SFX by Ex Libris Inc.

Title:	Novel mutation in the ATP-binding site of theMET oncogene tyrosine kinase in a HPRCC family
Source:	International Journal of Cancer [0020-7136] Olivero, Martina yr:1999

Basic

Full text

Full text available via Wiley Online Library All Journals

Year:

Volume:

Issue:

Start Page:

Full text available via Wiley Online Library Full Collection 2019

Year:

Volume:

Issue:

Start Page:

Full text available via Wiley Online Library STM 2011

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Park, M. "Mechanism of met oncogene activation." Cell 45.6 (1986): 895-904.
description	2.	Comoglio, Paolo M. "Drug development of MET inhibitors: targeting oncogene addiction and expedience." Nature reviews. Drug discovery 7.6 (2008): 504-516.
description	3.	Stoker, M. "Scatter factor is a fibroblast-derived modulator of epithelial cell mobility." Nature 327.6119 (1987): 239-242.
description	4.	COOPER, C. "MOLECULAR-CLONING OF A NEW TRANSFORMING GENE FROM A CHEMICALLY TRANSFORMED HUMAN CELL-LINE." Nature 311.5981 (1984): 29-33.
description	5.	Langley, Robert R R. "Tumor cell-organ microenvironment interactions in the pathogenesis of cancer metastasis." Endocrine reviews 28.3 (2007): 297-321.
description	6.	Peschard, P. "From Tpr-Met to Met, tumorigenesis and tubes." Oncogene 26.9 (2007): 1276-85.
description	7.	Li, YJ. "1,25-dihydroxyvitamin D-3 inhibits renal interstitial myofibroblast activation by inducing hepatocyte growth factor expression." Kidney international (2005): 1500-1510.
description	8.	Boller, A. "Heat capacity measurement by modulated DSC at constant temperature." Journal of thermal analysis 42.2: 307-330.
description	9.	Lagerström, Malin C C. "Structural diversity of G protein-coupled receptors and significance for drug discovery." Nature reviews. Drug discovery 7.4 (2008): 339-57.
description	10.	Peruzzi, B. "Targeting the c-Met signaling pathway in cancer." Clinical cancer research 12.12 (2006): 3657-60.
description	11.	Rosenberg, Saul H W. "An inhibitor of Bcl-2 family proteins induces regression of solid tumours." Nature 435.7042 (2005): 677-81.
description	12.	Wright, K M M. "Apoptosome dependent caspase-3 activation pathway is non-redundant and necessary for apoptosis in sympathetic neurons." Cell death and differentiation 14.3 (2007): 625-633.
description	13.	Gavathiotis, E. "BAX activation is initiated at a novel interaction site." Nature 455.7216 (2008): 1076-81.
description	14.	Overington, John P. "How many drug targets are there?" Nature reviews. Drug discovery 5.12 (2006): 993-6.
description	15.	Corso, S. "Cancer therapy: can the challenge be MET?" Trends in molecular medicine 11.6: 284-292.
description	16.	Gotoh, Y E. "Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery." Cell 91.2 (1997): 231-41.
description	17.	Marullo, S. "An escort for GPCRs: implications for regulation of receptor density at the cell surface." Trends in Pharmacological Sciences 29.10 (2008): 528-35.
description	18.	Bolanos-Garcia, Victor M. "MET meet adaptors: functional and structural implications in downstream signalling mediated by the Met receptor." Molecular and cellular biochemistry 276.1-2 (2005): 149-57.
description	19.	Schiöth, Helgi B B. "The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints." Molecular pharmacology 63.6 (2003): 1256-72.
description	20.	Bottaro, D P P. "Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product." Science 251.4995 (1991): 802-4.